{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,15]],"date-time":"2026-03-15T07:10:22Z","timestamp":1773558622946,"version":"3.50.1"},"reference-count":67,"publisher":"Bentham Science Publishers Ltd.","issue":"15","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["EMIDDT"],"published-print":{"date-parts":[[2024,12]]},"abstract":"<jats:sec>\n                    <jats:title>Objective:<\/jats:title>\n                    <jats:p>Patients with impaired glucose metabolism have increased thyroid volume\nand a higher prevalence of nodules. Yet, some studies show that there is an improvement in\nthese thyroid parameters after diabetes treatment. Our observational study aimed to reveal the\neffect of treatment on thyroid function, thyroid volume, and the presence of nodules in newly\ndiagnosed type 2 diabetes mellitus (T2DM) patients who were started on metformin treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Euthyroid and subclinically hypothyroid patients with a serum TSH level of &lt;10 mU\/L,\nwho were newly diagnosed with T2DM and started on metformin as an antidiabetic treatment and\nnot used any thyroid medication previously, were included in our study. Patients' characteristics\nwere recorded. Baseline and 6th-month serum thyroid function tests were scheduled. Baseline and\n6th-month thyroid gland characteristics were examined by thyroid ultrasonography.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A total of 101 (37 males, 64 females) newly diagnosed T2DM patients with euthyroid\n(n=95) or subclinical hypothyroidism (n=6) were included in the study. The mean age of the patients\nwas 53.02 \u00b1 11.9 years, and the mean BMI was 29.60 \u00b1 3.9 kg\/m2. Fifty-two (52%) patients\nwere classified as obese. Body weight, BMI, serum TSH, ALT, Anti-TPO levels, and thyroid volume\ndecreased significantly in the 6th-month compared to baseline values (p = 0.000; p = 0.000; p\n= 0.011; p = 0.022; p = 0.000, respectively). Serum anti-Tg, fT4, fT3 levels, and thyroid nodule\ncount did not change significantly. A high agreement was found between the baseline and 6thmonth\nnodule counts (gamma= 0.886; p &lt;0.001) and the presence of multi-nodularity in the thyroid\n(gamma= 0.941; p &lt;0.001), but no significant change was observed. Anti-TPO levels showed\na significant decrease in both with and without obesity groups at the end of 6 months (p = 0.003, p\n= 0.009, respectively). Serum TSH level decreased significantly only in non-obese subjects (p =\n0.004), and thyroid volume decreased significantly only in obese subjects (p = 0.000).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>Our results suggest that metformin treatment significantly reduces body weight,\nBMI, thyroid volume, and serum TSH, ALT, and Anti-TPO levels in patients with newly diagnosed\nT2DM. Moreover, serum TSH levels showed a significant decrease in non-obese subjects,\nwhile thyroid volume showed a significant decrease in obese subjects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0118715303307313240315162000","type":"journal-article","created":{"date-parts":[[2024,4,27]],"date-time":"2024-04-27T06:27:00Z","timestamp":1714199220000},"page":"1842-1855","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Metformin Therapy on Thyroid Volume and Functions in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Single-center Prospective Study"],"prefix":"10.2174","volume":"24","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1796-3845","authenticated-orcid":true,"given":"Mehtap Evran","family":"Olgun","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Division of Endocrinology and Metabolism, Faculty of Medicine, Cukurova University,Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4009-688X","authenticated-orcid":true,"given":"Gizem","family":"Pire","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7642-9546","authenticated-orcid":true,"given":"\u0130sa Burak","family":"G\u00fcney","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine, Faculty of Medicine, Cukurova University, Adana, Turkey"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","author":"Masharani U.","year":"2011","unstructured":"Masharani U.;  Greenspan\u2019s Basic and Clinical Endocrinology  2011","journal-title":"Greenspan\u2019s Basic and Clinical Endocrinology"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1111\/j.1745-7599.2002.tb00113.x","volume":"14","author":"Goolsby M.J.","year":"2002","unstructured":"Goolsby M.J.; Blackwell J.; Identification, evaluation, and treatment of overweight and obese adults. J Am Acad Nurse Pract  2002,14(5),196-198","journal-title":"J Am Acad Nurse Pract"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"334","DOI":"10.5603\/EP.2017.0026","volume":"68","author":"Frontczak R.A.","year":"2017","unstructured":"Frontczak R.A.; Majchrzak A.; Zi\u00f3\u0142kiewicz Z.D.; Insulin resistance in endocrine disorders - Treatment options. Endokrynol Pol  2017,68(3),334-351","journal-title":"Endokrynol Pol"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1080\/02841850600806308","volume":"47","author":"Junik R.","year":"2006","unstructured":"Junik R.; Kozinski M.; Kozinska D.K.; Thyroid ultrasound in diabetic patients without overt thyroid disease. Acta Radiol  2006,47(7),687-691","journal-title":"Acta Radiol"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"824","DOI":"10.1590\/0004-2730000003418","volume":"58","author":"Duran A.O.","year":"2014","unstructured":"Duran A.O.; Anil C.; Gursoy A.; Nar A.; Inanc M.; Bozkurt O.; Tutuncu N.B.; Thyroid volume in patients with glucose metabolism disorders. Arq Bras Endocrinol Metabol  2014,58(8),824-827","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1016\/j.metabol.2013.01.009","volume":"62","author":"Anil C.","year":"2013","unstructured":"Anil C.; Akkurt A.; Ayturk S.; Kut A.; Gursoy A.; Impaired glucose metabolism is a risk factor for increased thyroid volume and nodule prevalence in a mild-to-moderate iodine deficient area. Metabolism  2013,62(7),970-975","journal-title":"Metabolism"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"1617458","DOI":"10.1155\/2017\/1617458","volume":"2017","author":"Tang Y.","year":"2017","unstructured":"Tang Y.; Yan T.; Wang G.; Chen Y.; Zhu Y.; Jiang Z.; Yang M.; Li C.; Li Z.; Yu P.; Wang S.; Zhu N.; Ren Q.; Ni C; Correlation between insulin resistance and thyroid nodule in type 2 diabetes mellitus. Int J Endocrinol  2017,2017,1617458","journal-title":"Int J Endocrinol"},{"key":"ref=8","first-page":"355","volume":"76","author":"Maxzud C.M.","year":"2016","unstructured":"Maxzud C.M.; Rasjido G.L.; Fregenal M.; Calafiore A.F.; Lanus C.M.; D\u2019Urso M.; Luciardi H.; Prevalence of thyroid dysfunction in patients with type 2 diabetes mellitus. Medicina  2016,76(6),355-358","journal-title":"Medicina"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"R43","DOI":"10.1530\/JOE-16-0450","volume":"233","author":"Meng X.","year":"2017","unstructured":"Meng X.; Xu S.; Chen G.; Derwahl M.; Liu C.; Metformin and thyroid disease. J Endocrinol  2017,233(1),R43-R51","journal-title":"J Endocrinol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1007\/s10654-013-9865-0","volume":"28","author":"Schmid D.","year":"2013","unstructured":"Schmid D.; Behrens G.; Jochem C.; Keimling M.; Leitzmann M.; Physical activity, diabetes, and risk of thyroid cancer: A systematic review and meta-analysis. Eur J Epidemiol  2013,28(12),945-958","journal-title":"Eur J Epidemiol"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12020-013-9942-x","volume":"45","author":"Balkan F.","year":"2014","unstructured":"Balkan F.; Onal E.D.; Usluogullari A.; Tuzun D.; Ozdemir D.; Inancli S.S.; Ersoy R.; Cakir B.; \u201cIs there any association between insulin resistance and thyroid cancer?: A case control study\u201d. Endocrine  2014,45(1),55-60","journal-title":"Endocrine"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.3390\/medicina59112013","volume":"59","author":"Grigoriadis G.","year":"2023","unstructured":"Grigoriadis G.; Koufakis T.; Kotsa K.; Epidemiological, pathophysiological, and clinical considerations on the interplay between thyroid disorders and type 2 diabetes mellitus. Medicina  2023,59(11),2013","journal-title":"Medicina"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1530\/EJE-13-0101","volume":"169","author":"Ittermann T.","year":"2013","unstructured":"Ittermann T.; Markus M.R.; Schipf S.; Derwahl M.; Meisinger C.; V\u00f6lzke H.; Metformin inhibits goitrogenous effects of type 2 diabetes. Eur J Endocrinol  2013,169(1),9-15","journal-title":"Eur J Endocrinol"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","volume":"20","author":"Foretz M.","year":"2014","unstructured":"Foretz M.; Guigas B.; Bertrand L.; Pollak M.; Viollet B.; Metformin: From mechanisms of action to therapies. Cell Metab  2014,20(6),953-966","journal-title":"Cell Metab"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"2421","DOI":"10.2147\/DDDT.S141675","volume":"11","author":"Wang Y.W.","year":"2017","unstructured":"Wang Y.W.; He S.J.; Feng X.; Cheng J.; Luo Y.T.; Tian L.; Huang Q.; Metformin: A review of its potential indications. Drug Des Devel Ther  2017,11,2421-2429","journal-title":"Drug Des Devel Ther"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"E510","DOI":"10.1210\/jc.2011-1754","volume":"97","author":"Chen G.","year":"2012","unstructured":"Chen G.; Xu S.; Renko K.; Derwahl M.; Metformin inhibits growth of thyroid carcinoma cells, suppresses self-renewal of derived cancer stem cells, and potentiates the effect of chemotherapeutic agents. J Clin Endocrinol Metab  2012,97(4),E510-E520","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"6295","DOI":"10.1007\/s13277-015-3315-4","volume":"36","author":"Han B.","year":"2015","unstructured":"Han B.; Cui H.; Kang L.; Zhang X.; Jin Z.; Lu L.; Fan Z.; Metformin inhibits thyroid cancer cell growth, migration, and EMT through the mTOR pathway. Tumour Biol  2015,36(8),6295-6304","journal-title":"Tumour Biol"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"e109852","DOI":"10.1371\/journal.pone.0109852","volume":"9","author":"Tseng C.H.","year":"2014","unstructured":"Tseng C.H.; Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes. PLoS One  2014,9(10),e109852","journal-title":"PLoS One"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"1115","DOI":"10.1016\/j.pharep.2016.07.002","volume":"68","author":"Krysiak R.","year":"2016","unstructured":"Krysiak R.; Szkr\u00f3bka W.; Okopie\u0144 B.; Sex-dependent effect of metformin on hypothalamic-pituitary-thyroid axis activity in patients with subclinical hypothyroidism. Pharmacol Rep  2016,68(6),1115-1119","journal-title":"Pharmacol Rep"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1547","DOI":"10.1007\/s40618-020-01445-9","volume":"44","author":"Cannarella R.","year":"2021","unstructured":"Cannarella R.; Condorelli R.A.; Barbagallo F.; Aversa A.; Calogero A.E.; La Vignera S.; TSH lowering effects of metformin: A possible mechanism of action. J Endocrinol Invest  2021,44(7),1547-1550","journal-title":"J Endocrinol Invest"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1055\/s-0034-1398621","volume":"123","author":"Krysiak R.","year":"2015","unstructured":"Krysiak R.; Szkrobka W.; Okopien B.; The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and subclinical hyperthyroidism. Exp Clin Endocrinol Diabetes  2015,123(4),205-208","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.pharep.2015.11.010","volume":"68","author":"Krysiak R.","year":"2016","unstructured":"Krysiak R.; Gilowska M.; Szkr\u00f3bka W.; Okopie\u0144 B.; The effect of metformin on the hypothalamic-pituitary-thyroid axis in patients with type 2 diabetes and amiodarone-induced hypothyroidism. Pharmacol Rep  2016,68(2),490-494","journal-title":"Pharmacol Rep"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2337\/cd17-0119","volume":"36","year":"2018","unstructured":"American Diabetes Association. Standards of medical care in diabetes\u20142018 abridged for primary care providers. Clin Diabetes  2018,36(1),14-37","journal-title":"Clin Diabetes"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1590\/S0004-27302013000300005","volume":"57","author":"Carvalho G.A.","year":"2013","unstructured":"Carvalho G.A.; Perez C.L.; Ward L.S.; The clinical use of thyroid function tests. Arq Bras Endocrinol Metabol  2013,57(3),193-204","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.clinbiochem.2016.06.007","volume":"49","author":"Singh R.J.","year":"2016","unstructured":"Singh R.J.; Kaur P.; Thyroid hormone testing in the 21st century. Clin Biochem  2016,49(12),843-845","journal-title":"Clin Biochem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1038\/sj.jhh.1002201","volume":"21","author":"Sarafidis P.A.","year":"2007","unstructured":"Sarafidis P.A.; Lasaridis A.N.; Nilsson P.M.; Pikilidou M.I.; Stafilas P.C.; Kanaki A.; Kazakos K.; Yovos J.; Bakris G.L.; Validity and reproducibility of HOMA-IR, 1\/HOMA-IR, QUICKI and McAuley\u2019s indices in patients with hypertension and type II diabetes. J Hum Hypertens  2007,21(9),709-716","journal-title":"J Hum Hypertens"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1038\/nrendo.2018.18","volume":"14","author":"Taylor P.N.","year":"2018","unstructured":"Taylor P.N.; Albrecht D.; Scholz A.; Buey G.G.; Lazarus J.H.; Dayan C.M.; Okosieme O.E.; Global epidemiology of hyperthyroidism and hypothyroidism. Nat Rev Endocrinol  2018,14(5),301-316","journal-title":"Nat Rev Endocrinol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1056\/NEJMcp1611144","volume":"376","author":"Peeters R.P.","year":"2017","unstructured":"Peeters R.P.; Subclinical hypothyroidism. N Engl J Med  2017,376(26),2556-2565","journal-title":"N Engl J Med"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0887-2171(96)90003-7","volume":"17","author":"Loevner L.A.","year":"1996","unstructured":"Loevner L.A.; Imaging of the thyroid gland. Semin Ultrasound CT MR  1996,17(6),539-562","journal-title":"Semin Ultrasound CT MR"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1016\/j.ecl.2021.12.002","volume":"51","author":"Burgos N.","year":"2022","unstructured":"Burgos N.; Ospina N.S.; Sipos J.A.; The future of thyroid nodule risk stratification. Endocrinol Metab Clin North Am  2022,51(2),305-321","journal-title":"Endocrinol Metab Clin North Am"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"1338","DOI":"10.1055\/s-2008-1070506","volume":"106","author":"Brunn J.","year":"1981","unstructured":"Brunn J.; Block U.; Ruf G.; Bos I.; Kunze W.P.; Scriba P.C.; Volumetric analysis of thyroid lobes by real-time ultrasound. Dtsch Med Wochenschr  1981,106(41),1338-1340","journal-title":"Dtsch Med Wochenschr"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1159\/000442821","volume":"25","author":"Anil C.","year":"2016","unstructured":"Anil C.; Kut A.; Atesagaoglu B.; Nar A.; Tutuncu B.N.; Gursoy A.; Metformin decreases thyroid volume and nodule size in subjects with insulin resistance: A preliminary study. Med Princ Pract  2016,25(3),233-236","journal-title":"Med Princ Pract"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","volume":"402","author":"Ong K.L.","year":"2023","unstructured":"Ong K.L.; Stafford L.K.; McLaughlin S.A.; Boyko E.J.; Vollset S.E.; Smith A.E.; Dalton B.E.; Duprey J.; Cruz J.A.; Hagins H.; Lindstedt P.A.; Aali A.; Abate Y.H.; Abate M.D.; Abbasian M.; Kangevari A.Z.; Kangevari A.M.; ElHafeez A.S.; Rabu A.R.; Abdulah D.M.; Abdullah A.Y.M.; Abedi V.; Abidi H.; Aboagye R.G.; Abolhassani H.; Gharbieh A.E.; Zaid A.A.; Adane T.D.; Adane D.E.; Addo I.Y.; Adegboye O.A.; Adekanmbi V.; Adepoju A.V.; Adnani Q.E.S.; Afolabi R.F.; Agarwal G.; Aghdam Z.B.; Botero A.M.; Arriagada A.C.E.; Duah A.W.; Ahinkorah B.O.; Ahmad D.; Ahmad R.; Ahmad S.; Ahmad A.; Ahmadi A.; Ahmadi K.; Ahmed A.; Ahmed A.; Ahmed L.A.; Ahmed S.A.; Ajami M.; Akinyemi R.O.; Hamad A.H.; Hasan A.S.M.; Ahdal A.T.M.A.; Alalwan T.A.; Al-Aly Z.; AlBataineh M.T.; Rabanal A.J.E.; Alemi S.; Ali H.; Alinia T.; Aljunid S.M.; Almustanyir S.; Raddadi A.L.R.M.; Guzman A.N.; Amare F.; Ameyaw E.K.; Amiri S.; Amusa G.A.; Andrei C.L.; Anjana R.M.; Ansar A.; Ansari G.; Moghaddam A.A.; Anyasodor A.E.; Arabloo J.; Aravkin A.Y.; Areda D.; Arifin H.; Arkew M.; Armocida B.; \u00c4rnl\u00f6v J.; Artamonov A.A.; Arulappan J.; Aruleba R.T.; Arumugam A.; Aryan Z.; Asemu M.T.; Jafarabadi A.M.; Askari E.; Asmelash D.; Burt A.T.; Athar M.; Athari S.S.; Atout M.M.W.; Burgos A.L.; Awaisu A.; Azadnajafabad S.; B D.B.; Babamohamadi H.; Badar M.; Badawi A.; Badiye A.D.; Baghcheghi N.; Bagheri N.; Bagherieh S.; Bah S.; Bahadory S.; Bai R.; Baig A.A.; Baltatu O.C.; Baradaran H.R.; Barchitta M.; Bardhan M.; Barengo N.C.; B\u00e4rnighausen T.W.; Barone M.T.U.; Barone-Adesi F.; Barrow A.; Bashiri H.; Basiru A.; Basu S.; Basu S.; Batiha A-M.M.; Batra K.; Bayih M.T.; Bayileyegn N.S.; Behnoush A.H.; Bekele A.B.; Belete M.A.; Belgaumi U.I.; Belo L.; Bennett D.A.; Bensenor I.M.; Berhe K.; Berhie A.Y.; Bhaskar S.; Bhat A.N.; Bhatti J.S.; Bikbov B.; Bilal F.; Bintoro B.S.; Bitaraf S.; Bitra V.R.; Mikanovic B.V.; Bodolica V.; Boloor A.; Brauer M.; Sayavera B.J.; Brenner H.; Butt Z.A.; Calina D.; Campos L.A.; Nonato C.I.R.; Cao Y.; Cao C.; Car J.; Carvalho M.; Orjuela C.C.A.; L\u00f3pez C.F.; Cerin E.; Chadwick J.; Chandrasekar E.K.; Chanie G.S.; Charan J.; Chattu V.K.; Chauhan K.; Cheema H.A.; Abebe C.E.; Chen S.; Cherbuin N.; Chichagi F.; Chidambaram S.B.; Cho W.C.S.; Choudhari S.G.; Chowdhury R.; Chowdhury E.K.; Chu D-T.; Chukwu I.S.; Chung S-C.; Coberly K.; Columbus A.; Contreras D.; Cousin E.; Criqui M.H.; Cruz-Martins N.; Cuschieri S.; Dabo B.; Dadras O.; Dai X.; Damasceno A.A.M.; Dandona R.; Dandona L.; Das S.; Dascalu A.M.; Dash N.R.; Dashti M.; Cervantes D.C.A.; De la G\u00f3ngora C.V.; Debele G.R.; Delpasand K.; Demisse F.W.; Demissie G.D.; Deng X.; Guti\u00e9rrez D.E.; Deo S.V.; Dervi\u0161evi\u0107 E.; Desai H.D.; Desale A.T.; Dessie A.M.; Desta F.; Dewan S.M.R.; Dey S.; Dhama K.; Dhimal M.; Diao N.; Diaz D.; Dinu M.; Diress M.; Djalalinia S.; Doan L.P.; Dongarwar D.; dos Figueiredo S.F.W.; Duncan B.B.; Dutta S.; Dziedzic A.M.; Edinur H.A.; Ekholuenetale M.; Ekundayo T.C.; Elgendy I.Y.; Elhadi M.; El-Huneidi W.; Elmeligy O.A.A.; Elmonem M.A.; Endeshaw D.; Esayas H.L.; Eshetu H.B.; Etaee F.; Fadhil I.; Fagbamigbe A.F.; Fahim A.; Falahi S.; Faris M.A.I.E.M.; Farrokhpour H.; Farzadfar F.; Fatehizadeh A.; Fazli G.; Feng X.; Ferede T.Y.; Fischer F.; Flood D.; Forouhari A.; Foroumadi R.; Koudehi F.M.; Gaidhane A.M.; Gaihre S.; Gaipov A.; Galali Y.; Ganesan B.; Gordillo G.M.A.; Gautam R.K.; Gebrehiwot M.; Gebrekidan K.G.; Gebremeskel T.G.; Getacher L.; Ghadirian F.; Ghamari S-H.; Nour G.M.; Ghassemi F.; Golechha M.; Goleij P.; Golinelli D.; Gopalani S.V.; Guadie H.A.; Guan S-Y.; Gudayu T.W.; Guimar\u00e3es R.A.; Guled R.A.; Gupta R.; Gupta K.; Gupta V.B.; Gupta V.K.; Gyawali B.; Haddadi R.; Hadi N.R.; Haile T.G.; Hajibeygi R.; Haj-Mirzaian A.; Halwani R.; Hamidi S.; Hankey G.J.; Hannan M.A.; Haque S.; Harandi H.; Harlianto N.I.; Hasan S.M.M.; Hasan S.S.; Hasani H.; Hassanipour S.; Hassen M.B.; Haubold J.; Hayat K.; Heidari G.; Heidari M.; Hessami K.; Hiraike Y.; Holla R.; Hossain S.; Hossain M.S.; Hosseini M-S.; Hosseinzadeh M.; Hosseinzadeh H.; Huang J.; Huda M.N.; Hussain S.; Huynh H-H.; Hwang B-F.; Ibitoye S.E.; Ikeda N.; Ilic I.M.; Ilic M.D.; Inbaraj L.R.; Iqbal A.; Islam S.M.S.; Islam R.M.; Ismail N.E.; Iso H.; Isola G.; Itumalla R.; Iwagami M.; Iwu C.C.D.; Iyamu I.O.; Iyasu A.N.; Jacob L.; Jafarzadeh A.; Jahrami H.; Jain R.; Jaja C.; Jamalpoor Z.; Jamshidi E.; Janakiraman B.; Jayanna K.; Jayapal S.K.; Jayaram S.; Jayawardena R.; Jebai R.; Jeong W.; Jin Y.; Jokar M.; Jonas J.B.; Joseph N.; Joseph A.; Joshua C.E.; Joukar F.; Jozwiak J.J.; Kaambwa B.; Kabir A.; Kabthymer R.H.; Kadashetti V.; Kahe F.; Kalhor R.; Kandel H.; Karanth S.D.; Karaye I.M.; Karkhah S.; Katoto P.D.M.C.; Kaur N.; Kazemian S.; Kebede S.A.; Khader Y.S.; Khajuria H.; Khalaji A.; Khan M.A.B.; Khan M.; Khan A.; Khanal S.; Khatatbeh M.M.; Khater A.M.; Khateri S.; khorashadizadeh F.; Khubchandani J.; Kibret B.G.; Kim M.S.; Kimokoti R.W.; Kisa A.; Kivim\u00e4ki M.; Kolahi A-A.; Komaki S.; Kompani F.; Koohestani H.R.; Korzh O.; Kostev K.; Kothari N.; Koyanagi A.; Krishan K.; Krishnamoorthy Y.; Kuate Defo B.; Kuddus M.; Kuddus M.A.; Kumar R.; Kumar H.; Kundu S.; Kurniasari M.D.; Kuttikkattu A.; La Vecchia C.; Lallukka T.; Larijani B.; Larsson A.O.; Latief K.; Lawal B.K.; Le T.T.T.; Le T.T.B.; Lee S.W.H.; Lee M.; Lee W-C.; Lee P.H.; Lee S.; Lee S.W.; Legesse S.M.; Lenzi J.; Li Y.; Li M-C.; Lim S.S.; Lim L-L.; Liu X.; Liu C.; Lo C-H.; Lopes G.; Lorkowski S.; Lozano R.; Lucchetti G.; Maghazachi A.A.; Mahasha P.W.; Mahjoub S.; Mahmoud M.A.; Mahmoudi R.; Mahmoudimanesh M.; Mai A.T.; Majeed A.; Majma Sanaye P.; Makris K.C.; Malhotra K.; Malik A.A.; Malik I.; Mallhi T.H.; Malta D.C.; Mamun A.A.; Mansouri B.; Marateb H.R.; Mardi P.; Martini S.; Martorell M.; Marzo R.R.; Masoudi R.; Masoudi S.; Mathews E.; Maugeri A.; Mazzaglia G.; Mekonnen T.; Meshkat M.; Mestrovic T.; Miao Jonasson J.; Miazgowski T.; Michalek I.M.; Minh L.H.N.; Mini G.K.; Miranda J.J.; Mirfakhraie R.; Mirrakhimov E.M.; Mirza-Aghazadeh-Attari M.; Misganaw A.; Misgina K.H.; Mishra M.; Moazen B.; Mohamed N.S.; Mohammadi E.; Mohammadi M.; Mohammadian-Hafshejani A.; Mohammadshahi M.; Mohseni A.; Mojiri-forushani H.; Mokdad A.H.; Momtazmanesh S.; Monasta L.; Moniruzzaman M.; Mons U.; Montazeri F.; Moodi Ghalibaf A.A.; Moradi Y.; Moradi M.; Moradi Sarabi M.; Morovatdar N.; Morrison S.D.; Morze J.; Mossialos E.; Mostafavi E.; Mueller U.O.; Mulita F.; Mulita A.; Murillo-Zamora E.; Musa K.I.; Mwita J.C.; Nagaraju S.P.; Naghavi M.; Nainu F.; Nair T.S.; Najmuldeen H.H.R.; Nangia V.; Nargus S.; Naser A.Y.; Nassereldine H.; Natto Z.S.; Nauman J.; Nayak B.P.; Ndejjo R.; Negash H.; Negoi R.I.; Nguyen H.T.H.; Nguyen D.H.; Nguyen P.T.; Nguyen V.T.; Nguyen H.Q.; Niazi R.K.; Nigatu Y.T.; Ningrum D.N.A.; Nizam M.A.; Nnyanzi L.A.; Noreen M.; Noubiap J.J.; Nzoputam O.J.; Nzoputam C.I.; Oancea B.; Odogwu N.M.; Odukoya O.O.; Ojha V.A.; Okati-Aliabad H.; Okekunle A.P.; Okonji O.C.; Okwute P.G.; Olufadewa I.I.; Onwujekwe O.E.; Ordak M.; Ortiz A.; Osuagwu U.L.; Oulhaj A.; Owolabi M.O.; Padron-Monedero A.; Padubidri J.R.; Palladino R.; Panagiotakos D.; Panda-Jonas S.; Pandey A.; Pandey A.; Perumal P.S.R.; Stoian P.A.M.; Pardhan S.; Parekh T.; Parekh U.; Pasovic M.; Patel J.; Patel J.R.; Paudel U.; Pepito V.C.F.; Pereira M.; Perico N.; Perna S.; Petcu I-R.; Rocha P.F.E.; Podder V.; Postma M.J.; Pourali G.; Pourtaheri N.; Prates E.J.S.; Qadir M.M.F.; Qattea I.; Raee P.; Rafique I.; Rahimi M.; Rahimifard M.; Movaghar R.V.; Rahman M.O.; Rahman M.A.; Rahman M.H.U.; Rahman M.; Rahman M.M.; Rahmani M.; Rahmani S.; Rahmanian V.; Rahmawaty S.; Rahnavard N.; Rajbhandari B.; Ram P.; Ramazanu S.; Rana J.; Rancic N.; Ranjha M.M.A.N.; Rao C.R.; Rapaka D.; Rasali D.P.; Rashedi S.; Rashedi V.; Rashid A.M.; Rashidi M-M.; Ratan Z.A.; Rawaf S.; Rawal L.; Redwan E.M.M.; Remuzzi G.; Rengasamy K.R.R.; Renzaho A.M.N.; Reyes L.F.; Rezaei N.; Rezaei N.; Rezaeian M.; Rezazadeh H.; Riahi S.M.; Rias Y.A.; Riaz M.; Ribeiro D.; Rodrigues M.; Rodriguez J.A.B.; Roever L.; Rohloff P.; Roshandel G.; Roustazadeh A.; Rwegerera G.M.; Saad A.M.A.; Saber-Ayad M.M.; Sabour S.; Sabzmakan L.; Saddik B.; Sadeghi E.; Saeed U.; Moghaddam S.S.; Safi S.; Safi S.Z.; Saghazadeh A.; Askari S.S.N.; Askari S.S.F.; Sahebkar A.; Sahoo S.S.; Sahoo H.; Rahman S.U.K.M.; Sajid M.R.; Salahi S.; Salahi S.; Saleh M.A.; Salehi M.A.; Salomon J.A.; Sanabria J.; Sanjeev R.K.; Sanmarchi F.; Milicevic S.M.M.; Sarasmita M.A.; Sargazi S.; Sathian B.; Sathish T.; Sawhney M.; Schlaich M.P.; Schmidt M.I.; Schuermans A.; Seidu A-A.; Kumar S.N.; Sepanlou S.G.; Sethi Y.; Seylani A.; Shabany M.; Shafaghat T.; Shafeghat M.; Shafie M.; Shah N.S.; Shahid S.; Shaikh M.A.; Shanawaz M.; Shannawaz M.; Sharfaei S.; Shashamo B.B.; Shiri R.; Shittu A.; Shivakumar K.M.; Shivalli S.; Shobeiri P.; Shokri F.; Shuval K.; Sibhat M.M.; Silva L.M.L.R.; Simpson C.R.; Singh J.A.; Singh P.; Singh S.; Siraj M.S.; Skryabina A.A.; Sohag A.A.M.; Soleimani H.; Solikhah S.; Zangbar S.M.S.; Somayaji R.; Sorensen R.J.D.; Starodubova A.V.; Sujata S.; Suleman M.; Sun J.; Sundstr\u00f6m J.; Seisdedos T.R.; Tabatabaei S.M.; Tabatabaeizadeh S-A.; Tabish M.; Taheri M.; Taheri E.; Taki E.; Tamuzi J.J.L.L.; Tan K-K.; Tat N.Y.; Taye B.T.; Temesgen W.A.; Temsah M-H.; Tesler R.; Thangaraju P.; Thankappan K.R.; Thapa R.; Tharwat S.; Thomas N.; Ticoalu J.H.V.; Tiyuri A.; Tonelli M.; Palone T.M.R.; Trico D.; Trihandini I.; Tripathy J.P.; Tromans S.J.; Tsegay G.M.; Tualeka A.R.; Tufa D.G.; Tyrovolas S.; Ullah S.; Upadhyay E.; Vahabi S.M.; Vaithinathan A.G.; Valizadeh R.; van Daalen K.R.; Vart P.; Varthya S.B.; Vasankari T.J.; Vaziri S.; Verma M.; Verras G-I.; Vo D.C.; Wagaye B.; Waheed Y.; Wang Z.; Wang Y.; Wang C.; Wang F.; Wassie G.T.; Wei M.Y.W.; Weldemariam A.H.; Westerman R.; Wickramasinghe N.D.; Wu Y.F.; Wulandari R.D.W.I.; Xia J.; Xiao H.; Xu S.; Xu X.; Yada D.Y.; Yang L.; Yatsuya H.; Yesiltepe M.; Yi S.; Yohannis H.K.; Yonemoto N.; You Y.; Zaman S.B.; Zamora N.; Zare I.; Zarea K.; Zarrintan A.; Zastrozhin M.S.; Zeru N.G.; Zhang Z-J.; Zhong C.; Zhou J.; Zieli\u0144ska M.; Zikarg Y.T.; Zodpey S.; Zoladl M.; Zou Z.; Zumla A.; Zuniga Y.M.H.; Magliano D.J.; Murray C.J.L.; Hay S.I.; Vos T.; Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: A systematic analysis for the global burden of disease study 2021. Lancet  2023,402(10397),203-234","journal-title":"Lancet"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.2337\/diacare.25.10.1737","volume":"25","author":"Viberti G.","year":"2002","unstructured":"Viberti G.; Kahn S.E.; Greene D.A.; Herman W.H.; Zinman B.; Holman R.R.; Haffner S.M.; Levy D.; Lachin J.M.; Berry R.A.; Heise M.A.; Jones N.P.; Freed M.I.; A diabetes outcome progression trial (ADOPT): An international multicenter study of the comparative efficacy of rosiglitazone, glyburide, and metformin in recently diagnosed type 2 diabetes. Diabetes Care  2002,25(10),1737-1743","journal-title":"Diabetes Care"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"1647","DOI":"10.2337\/diacare.27.7.1647","volume":"27","author":"Charbonnel B.","year":"2004","unstructured":"Charbonnel B.; Dormandy J.; Erdmann E.; Benedetti M.M.; Skene A.; The prospective pioglitazone clinical trial in macrovascular events (proactive): Can pioglitazone reduce cardiovascular events in diabetes? Study design and baseline characteristics of 5238 patients. Diabetes Care  2004,27(7),1647-1653","journal-title":"Diabetes Care"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"1463","DOI":"10.2337\/db07-1515","volume":"57","author":"Bachmakov I.","year":"2008","unstructured":"Bachmakov I.; Glaeser H.; Fromm M.F.; K\u00f6nig J.; Interaction of oral antidiabetic drugs with hepatic uptake transporters: Focus on organic anion transporting polypeptides and organic cation transporter 1. Diabetes  2008,57(6),1463-1469","journal-title":"Diabetes"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"817","DOI":"10.3109\/00498254.2010.520349","volume":"40","author":"Choi M.K.","year":"2010","unstructured":"Choi M.K.; Jin Q.R.; Ahn S.H.; Bae M.A.; Song I.S.; Sitagliptin attenuates metformin-mediated AMPK phosphorylation through inhibition of organic cation transporters. Xenobiotica  2010,40(12),817-825","journal-title":"Xenobiotica"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s40262-015-0270-6","volume":"54","author":"Stage T.B.","year":"2015","unstructured":"Stage T.B.; Br\u00f8sen K.; Christensen M.M.H.; A comprehensive review of drug\u2013drug interactions with metformin. Clin Pharmacokinet  2015,54(8),811-824","journal-title":"Clin Pharmacokinet"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1111\/bcp.12476","volume":"78","author":"Cho S.K.","year":"2014","unstructured":"Cho S.K.; Kim C.O.; Park E.S.; Chung J.Y.; Verapamil decreases the glucose\u2010lowering effect of metformin in healthy volunteers. Br J Clin Pharmacol  2014,78(6),1426-1432","journal-title":"Br J Clin Pharmacol"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1016\/S0002-9343(97)00254-4","volume":"103","author":"Garber A.J.","year":"1997","unstructured":"Garber A.J.; Duncan T.G.; Goodman A.M.; Mills D.J.; Rohlf J.L.; Efficacy of metformin in type II diabetes: Results of a double-blind, placebo-controlled, dose-response trial. Am J Med  1997,103(6),491-497","journal-title":"Am J Med"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1097\/MED.0000000000000095","volume":"21","author":"Malin S.K.","year":"2014","unstructured":"Malin S.K.; Kashyap S.R.; Effects of metformin on weight loss. Curr Opin Endocrinol Diabetes Obes  2014,21(5),323-329","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"1601","DOI":"10.1007\/s00125-017-4361-9","volume":"60","author":"Aroda V.R.","year":"2017","unstructured":"Aroda V.R.; Knowler W.C.; Crandall J.P.; Perreault L.; Edelstein S.L.; Jeffries S.L.; Molitch M.E.; Pi-Sunyer X.; Darwin C.; Stoddard H.B.M.; Temprosa M.; Kahn S.E.; Nathan D.M.; Metformin for diabetes prevention: Insights gained from the diabetes prevention program\/diabetes prevention program outcomes study. Diabetologia  2017,60(9),1601-1611","journal-title":"Diabetologia"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"S105","DOI":"10.1016\/j.dsx.2016.12.017","volume":"11","author":"Jali M.V.","year":"2017","unstructured":"Jali M.V.; Kambar S.; Jali S.M.; Pawar N.; Nalawade P.; Prevalence of thyroid dysfunction among type 2 diabetes mellitus patients. Diabetes Metab Syndr  2017,11(S1),S105-S108","journal-title":"Diabetes Metab Syndr"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"e0135233","DOI":"10.1371\/journal.pone.0135233","volume":"10","author":"Han C.","year":"2015","unstructured":"Han C.; He X.; Xia X.; Li Y.; Shi X.; Shan Z.; Teng W.; Subclinical hypothyroidism and type 2 diabetes: A systematic review and meta-analysis. PLoS One  2015,10(8),e0135233","journal-title":"PLoS One"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1002\/jcph.373","volume":"55","author":"Krysiak R.","year":"2015","unstructured":"Krysiak R.; Okopien B.; The effect of metformin on the hypothalamic\u2013pituitary\u2013thyroid axis in women with polycystic ovary syndrome and subclinical hypothyroidism. J Clin Pharmacol  2015,55(1),45-49","journal-title":"J Clin Pharmacol"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"C1549","DOI":"10.1152\/ajpcell.00279.2010","volume":"299","author":"Bogachus L.D.","year":"2010","unstructured":"Bogachus L.D.; Turcotte L.P.; Genetic downregulation of AMPK-\u03b1 isoforms uncovers the mechanism by which metformin decreases FA uptake and oxidation in skeletal muscle cells. Am J Physiol Cell Physiol  2010,299(6),C1549-C1561","journal-title":"Am J Physiol Cell Physiol"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"e128","DOI":"10.3399\/bjgp10X483562","volume":"60","author":"Khan N.F.","year":"2010","unstructured":"Khan N.F.; Harrison S.E.; Rose P.W.; Validity of diagnostic coding within the General Practice Research Database: A systematic review. Br J Gen Pract  2010,60(572),e128-e136","journal-title":"Br J Gen Pract"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2337\/dc09-0273","volume":"32","author":"Cappelli C.","year":"2009","unstructured":"Cappelli C.; Rotondi M.; Pirola I.; Agosti B.; Gandossi E.; Valentini U.; De Martino E.; Cimino A.; Chiovato L.; Rosei A.E.; Castellano M.; TSH-lowering effect of metformin in type 2 diabetic patients: differences between euthyroid, untreated hypothyroid, and euthyroid on L-T4 therapy patients. Diabetes Care  2009,32(9),1589-1590","journal-title":"Diabetes Care"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s12020-017-1462-7","volume":"59","author":"Severo D.M.","year":"2018","unstructured":"Severo D.M.; Andrade S.T.; Junior C.V.; Naujorks A.A.; Gus M.; Schaan B.D.; Metformin effect on TSH in subclinical hypothyroidism: Randomized, double-blind, placebo-controlled clinical trial. Endocrine  2018,59(1),66-71","journal-title":"Endocrine"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1530\/EJE-12-0225","volume":"167","author":"Cappelli C.","year":"2012","unstructured":"Cappelli C.; Rotondi M.; Pirola I.; Agosti B.; Formenti A.; Zarra E.; Valentini U.; Leporati P.; Chiovato L.; Castellano M.; Thyreotropin levels in diabetic patients on metformin treatment. Eur J Endocrinol  2012,167(2),261-265","journal-title":"Eur J Endocrinol"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"105","DOI":"10.4021\/jem188w","volume":"3","author":"Rajput R.","year":"2013","unstructured":"Rajput R.; Saini M.; Rajput M.; Shankar V.; Effects of metformin on thyroid function in patients of subclinical hypothyreoidism. J Endocrinol Metab  2013,3(4\u20135),105-110","journal-title":"J Endocrinol Metab"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4149\/BLL_2016_084","volume":"117","author":"Dimic D.","year":"2016","unstructured":"Dimic D.; Golubovic M.V.; Radenkovic S.; Radojkovic D.; Pesic M.; The effect of metformin on TSH levels in euthyroid and hypothyroid newly diagnosed diabetes mellitus type 2 patients. Bratisl Med J  2016,117(8),433-435","journal-title":"Bratisl Med J"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/08916934.2020.1789969","volume":"53","author":"Jia X.","year":"2020","unstructured":"Jia X.; Zhai T.; Zhang J.; Metformin reduces autoimmune antibody levels in patients with Hashimoto\u2019s thyroiditis: A systematic review and meta-analysis. Autoimmunity  2020,53(6),353-361","journal-title":"Autoimmunity"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/art.39296","volume":"67","author":"Wang H.","year":"2015","unstructured":"Wang H.; Li T.; Chen S.; Gu Y.; Ye S.; Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof\u2010of\u2010concept trial of metformin. Arthritis Rheumatol  2015,67(12),3190-3200","journal-title":"Arthritis Rheumatol"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1016\/j.vaccine.2017.03.078","volume":"35","author":"Diaz A.","year":"2017","unstructured":"Diaz A.; Romero M.; Vazquez T.; Lechner S.; Blomberg B.B.; Frasca D.; Metformin improves in vivo and in vitro B cell function in individuals with obesity and Type-2 Diabetes. Vaccine  2017,35(20),2694-2700","journal-title":"Vaccine"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"2661","DOI":"10.4049\/jimmunol.1403088","volume":"198","author":"Lee S.Y.","year":"2017","unstructured":"Lee S.Y.; Moon S.J.; Kim E.K.; Seo H.B.; Yang E.J.; Son H.J.; Kim J.K.; Min J.K.; Park S.H.; Cho M.L.; Metformin suppresses systemic autoimmunity in roquinsan\/san mice through inhibiting B cell differentiation into plasma cells via regulation of AMPK\/mTOR\/STAT3. J Immunol  2017,198(7),2661-2670","journal-title":"J Immunol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1111\/j.1365-2265.2012.04468.x","volume":"78","author":"D\u00edez J.J.","year":"2013","unstructured":"D\u00edez J.J.; Iglesias P.; Relationship between serum thyrotropin concentrations and metformin therapy in euthyroid patients with type 2 diabetes. Clin Endocrinol  2013,78(4),505-511","journal-title":"Clin Endocrinol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"1138","DOI":"10.1503\/cmaj.140688","volume":"186","author":"Fournier J.P.","year":"2014","unstructured":"Fournier J.P.; Yin H.; Yu O.H.Y.; Azoulay L.; Metformin and low levels of thyroid-stimulating hormone in patients with type 2 diabetes mellitus. CMAJ  2014,186(15),1138-1145","journal-title":"CMAJ"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"e13283","DOI":"10.7759\/cureus.13283","volume":"13","author":"Haroon S.M.","year":"2021","unstructured":"Haroon S.M.; Khan K.; Maqsood M.; Iqbal S.; Aleem M.; Khan T.U.; Exploring the effect of metformin to lower thyroid-stimulating hormone in euthyroid and hypothyroid type-2 diabetic patients. Cureus  2021,13(2),e13283","journal-title":"Cureus"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1089\/met.2010.0026","volume":"9","author":"Rezz\u00f3nico J.","year":"2011","unstructured":"Rezz\u00f3nico J.; Rezz\u00f3nico M.; Pusiol E.; Pitoia F.; Niepomniszcze H.; Metformin treatment for small benign thyroid nodules in patients with insulin resistance. Metab Syndr Relat Disord  2011,9(1),69-75","journal-title":"Metab Syndr Relat Disord"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"494","DOI":"10.3389\/fendo.2018.00494","volume":"9","author":"Sui M.","year":"2018","unstructured":"Sui M.; Yu Y.; Zhang H.; Di H.; Liu C.; Fan Y.; Efficacy of metformin for benign thyroid nodules in subjects with insulin resistance: A systematic review and meta-analysis. Front Endocrinol  2018,9,494","journal-title":"Front Endocrinol"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1177\/1479164110391917","volume":"8","author":"Morteza Taghavi S.","year":"2011","unstructured":"Morteza Taghavi S.; Rokni H.; Fatemi S.; Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism. Diab Vasc Dis Res  2011,8(1),47-48","journal-title":"Diab Vasc Dis Res"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/met.2014.0158","volume":"13","author":"Blanc E.","year":"2015","unstructured":"Blanc E.; Ponce C.; Brodschi D.; Nepote A.; Barreto A.; Schnitman M.; Fossati P.; Salgado P.; Cejas C.; Faingold C.; Musso C.; Brenta G.; Association between worse metabolic control and increased thyroid volume and nodular disease in elderly adults with metabolic syndrome. Metab Syndr Relat Disord  2015,13(5),221-226","journal-title":"Metab Syndr Relat Disord"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1089\/thy.2007.0223","volume":"18","author":"Rezzonico J.","year":"2008","unstructured":"Rezzonico J.; Rezzonico M.; Pusiol E.; Pitoia F.; Niepomniszcze H.; Introducing the thyroid gland as another victim of the insulin resistance syndrome. Thyroid  2008,18(4),461-464","journal-title":"Thyroid"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3109\/07435800.2012.699987","volume":"38","author":"Kouidhi S.","year":"2013","unstructured":"Kouidhi S.; Berhouma R.; Ammar M.; Rouissi K.; Jarboui S.; Froidevaux C.M.S.; Seugnet I.; Abid H.; Bchir F.; Demeneix B.; Guissouma H.; Elgaaied A.B.; Relationship of thyroid function with obesity and type 2 diabetes in euthyroid Tunisian subjects. Endocr Res  2013,38(1),15-23","journal-title":"Endocr Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1007\/s12020-007-9012-3","volume":"32","author":"Isidro M.L.","year":"2007","unstructured":"Isidro M.L.; Pen\u00edn M.A.; Nemi\u00f1a R.; Cordido F.; Metformin reduces thyrotropin levels in obese, diabetic women with primary hypothyroidism on thyroxine replacement therapy. Endocr J  2007,32(1),79-82","journal-title":"Endocr J"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/17843286.2018.1439273","volume":"73","author":"R\u0103c\u0103t\u0103ianu N.","year":"2018","unstructured":"R\u0103c\u0103t\u0103ianu N.; Bolboac\u0103 S.D.; T\u0103ut S.A.V.; M\u00e2rza S.; Moga D.; Valea A.; Ghervan C.; The effect of metformin treatment in obese insulin-resistant patients with euthyroid goiter. Acta Clin Belg  2018,73(5),1-7","journal-title":"Acta Clin Belg"}],"container-title":["Endocrine, Metabolic &amp; Immune Disorders - Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715303307313240315162000","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/229348\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0118715303307313240315162000","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T09:45:02Z","timestamp":1761299102000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/229348\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":67,"journal-issue":{"issue":"15","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0118715303307313240315162000","relation":{},"ISSN":["1871-5303"],"issn-type":[{"value":"1871-5303","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Double blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2024-01-29","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-01","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-03-05","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2024-09-24","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}